324 related articles for article (PubMed ID: 21569543)
1. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
[TBL] [Abstract][Full Text] [Related]
2. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
[TBL] [Abstract][Full Text] [Related]
3. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Mosller M
Clin Cardiol; 1997 Aug; 20(8):704-10. PubMed ID: 9259163
[TBL] [Abstract][Full Text] [Related]
4. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide.
Brendorp B; Elming H; Jun L; Køber L; Torp-Pedersen C;
Clin Cardiol; 2003 May; 26(5):219-25. PubMed ID: 12769249
[TBL] [Abstract][Full Text] [Related]
6. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
Pedersen OD; Brendorp B; Elming H; Pehrson S; Køber L; Torp-Pedersen C
Card Electrophysiol Rev; 2003 Sep; 7(3):220-4. PubMed ID: 14739717
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L;
Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337
[TBL] [Abstract][Full Text] [Related]
8. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Køber L; Bloch Thomsen PE; Møller M; Torp-Pedersen C; Carlsen J; Sandøe E; Egstrup K; Agner E; Videbaek J; Marchant B; Camm AJ;
Lancet; 2000 Dec; 356(9247):2052-8. PubMed ID: 11145491
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Pedersen OD; Bagger H; Keller N; Marchant B; Køber L; Torp-Pedersen C
Circulation; 2001 Jul; 104(3):292-6. PubMed ID: 11457747
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
Koene RJ; Menon V; Cantillon DJ; Dresing TJ; Martin DO; Kanj M; Saliba WI; Tarakji KG; Baranowski B; Hussein AA; Tchou PJ; Bhargava M; Callahan TD; Rickard JW; Niebauer MJ; Chung MK; Varma N; Wilkoff BL; Lindsay BD; Wazni OM
Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008168. PubMed ID: 32538135
[TBL] [Abstract][Full Text] [Related]
11. [Dofetilide to patients with heart failure and left ventricular dysfunction].
Torp-Pedersen CT; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen JE; Videbaek J
Ugeskr Laeger; 2000 Oct; 162(44):5948-53. PubMed ID: 11094565
[TBL] [Abstract][Full Text] [Related]
12. Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
Brendorp B; Elming H; Jun L; Køber L; Torp-Pedersen C;
Eur J Heart Fail; 2002 Mar; 4(2):201-6. PubMed ID: 11959050
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
14. Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide.
Brendorp B; Elming H; Jun L; Køber L; Malik M; Jensen GB; Torp-Pedersen C;
Circulation; 2001 Mar; 103(10):1422-7. PubMed ID: 11245647
[TBL] [Abstract][Full Text] [Related]
15. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
Latini R
Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277
[No Abstract] [Full Text] [Related]
16. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
Singh SN
Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
[TBL] [Abstract][Full Text] [Related]
17. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
Sohns C; Zintl K; Zhao Y; Dagher L; Andresen D; Siebels J; Wegscheider K; Sehner S; Boersma L; Merkely B; Pokushalov E; Sanders P; Schunkert H; Bänsch D; Mahnkopf C; Brachmann J; Marrouche NF
Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008461. PubMed ID: 32903044
[TBL] [Abstract][Full Text] [Related]
18. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
McClellan KJ; Markham A
Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
[TBL] [Abstract][Full Text] [Related]
19. Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy.
Brendorp B; Torp-Pedersen C; Elming H; Køber L
Eur Heart J; 2003 Feb; 24(3):274-9. PubMed ID: 12590905
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
